Roche, global pioneers in pharmaceuticals and diagnostics, is soon to take ownership of their new state-of-the-art Roche Diagnostics Cape Town site.
This custom-built 8 630m2 building, which is situated at Brackengate 2, was jointly developed for Roche by VDMV Property Holdings and Redefine Ltd, and will feature a laboratory, biotech production and office workspace.
This new building will allow Roche to increase their research, development, and biotech production capabilities and to deliver truly innovative products to patients and customers now and well into the future. Roche plans for nearly 300 employees to work from this new Cape Town site.
The Roche Group, which has its headquarters in Basel, Switzerland, is active in over 100 countries and in 2019 employed about 98,000 people worldwide. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology, and diseases of the central nervous system. Roche is also the world leader in invitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.
More than thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Moreover, for the eleventh consecutive year, Roche has been recognised as one of the most sustainable companies in the Pharmaceuticals Industry by the Dow Jones Sustainability Indices (DJSI).
For more information contact VDMV on +27 (0) 21 9704560 or email: info@vdmv.co.za. Alternatively visit www.vdmv.co.za.
